Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease.
Femke Crouwel,Melek Simsek,Marjon A de Boer,Chris J J Mulder, Emma M van Andel,Rob H Creemers,Dirk P van Asseldonk,Ad A van Bodegraven,Carmen S Horjus,Marijn C Visschedijk, Angelique L M Weusthuis,Margien L Seinen,Bindia Jharap,Fiona D M van Schaik,Ishfaq Ahmad,Paul J Boekema,Greetje J Tack, Louktje Wormmeester,Maurice W M D Lutgens, Petra G A van Boeckel,Lennard P L Gilissen, Marjon Kerkhof,Maurice Russel,Frank Hoentjen, Maartje E Bartelink,Johan P Kuijvenhoven,Jeroen W J Maljaars,Willemijn A van Dop, Janneke Wonders,Michael M P J A van der Voorn,Hans J C Buiter,Nanne K de Boer Journal of Crohn's & colitis（2022）
摘要
In this large case series the use of thioguanine during pregnancy is not associated in excess with adverse maternal or neonatal outcomes.
更多查看译文
关键词
Inflammatory Bowel Disease,Pregnancy,Thioguanine
AI 理解论文
溯源树
样例
